sameAs
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphomaClonality of angioimmunoblastic lymphadenopathy and implications for its evolution to malignant lymphomaCooperative epigenetic modulation by cancer amplicon genesCharacterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United StatesRevised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International WorkshopPeripheral T-cell and NK-cell lymphomas in the WHO classification: pearls and pitfallsThe World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997Peripheral T-cell lymphoma with Reed-Sternberg-like cells of B-cell phenotype and genotype associated with Epstein-Barr virus infectionDetection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphomaIsochromosome 7q: the primary cytogenetic abnormality in hepatosplenic gammadelta T cell lymphomaA revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study GroupMalignant lymphoma and erythrophagocytosis simulating malignant histiocytosisHepatosplenic T-cell lymphoma: a distinct clinicopathologic entity of cytotoxic gamma delta T-cell originTwenty years of MOPP therapy for Hodgkin's diseaseOncogenically active MYD88 mutations in human lymphomaStromal gene signatures in large-B-cell lymphomasComposite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection.Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH.Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project.Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.Phase II and dose-escalation with or without granulocyte colony-stimulating factor study of 9-aminocamptothecin in relapsed and refractory lymphomas.Nature and importance of follicular lymphoma precursors.Immunoguided laser assisted microdissection techniques for DNA methylation analysis of archival tissue specimens.Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphomaCutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases.CNS involvement in primary mediastinal large B-cell lymphoma.The role of tumor histogenesis, FDG-PET, and short-course EPOCH with dose-dense rituximab (SC-EPOCH-RR) in HIV-associated diffuse large B-cell lymphoma.Lymphoma classification--from controversy to consensus: the R.E.A.L. and WHO Classification of lymphoid neoplasms.Why is it crucial to reintegrate pathology into cancer research?Somatic FAS mutations are common in patients with genetically undefined autoimmune lymphoproliferative syndrome.Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling.Gall bladder and extrahepatic bile duct lymphomas: clinicopathological observations and biological implications.Durable remission of mantle cell lymphoma relapsing a third time after allogeneic hematopoietic stem cell transplantation treated with rituximab, bortezomib, donor lymphocytes, and pegylated interferon.ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.Nodal and extranodal plasmacytomas expressing immunoglobulin a: an indolent lymphoproliferative disorder with a low risk of clinical progressionEnteropathy-associated T-cell lymphoma: clinical and histological findings from the international peripheral T-cell lymphoma project.Primary mediastinal large B-cell lymphoma, classic Hodgkin lymphoma presenting in the mediastinum, and mediastinal gray zone lymphoma: what is the oncologist to do?IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas.
P50
Q24319026-2582CE67-636C-4BA1-8A48-B96EE41DD627Q24563775-F5DAE24A-E6DD-4E5C-9B03-1F0937BDC963Q24608701-79F3CC74-73C9-43B4-89B9-4740E95499D6Q24617384-BC83058E-792B-4F45-9C23-974D78FBAD9BQ24632569-307A7113-67AF-4984-A159-3F258DEF4BC3Q27004241-E732578A-4163-4132-A0B6-C0BE3A1EF8EBQ28142473-5A2D3D72-C5C4-4A0E-A1FB-97F4D8605A08Q28143029-4AFC55A8-F5E0-4EA5-A69B-3689CD4AD02FQ28145960-4660A15F-B2F7-4F6E-8CC7-25324AD0C2DFQ28186343-866CFE72-35D7-4311-B16F-6E7127F0F860Q28246671-1156903D-6847-41E0-9951-FFB1183CD8EBQ28246957-6392F583-B85E-4872-9016-3410C2C0F027Q28271261-595694F7-6DE4-43DC-8452-F510D58350A6Q28298446-AF751C50-8FC6-44BE-B0E8-8641E822379FQ28299944-BA03F243-7F52-450F-8CCD-C85B906CC454Q28301648-1A762603-4501-4068-8512-5689BD906C01Q28302107-AEB57266-D5CE-4055-98C6-34620646F912Q30711809-0C8BFAB0-FC4A-45ED-877E-8C0A885D8F56Q31510390-CCC238BE-39BC-450B-A729-8FD404839146Q33393849-C5C417F9-BCE7-4E06-A1CD-C211FDDF1EA5Q33394324-9C0CFF51-1E61-46ED-9258-5C2FFEB11426Q33503047-2B72E90A-7012-4636-BF05-70A52F649E31Q33558757-ECC62781-2685-4F51-9544-94B7061FC27FQ33562640-C1149495-1C19-47CB-AF2A-4972A00DEFD3Q33585243-DF88759D-8E06-4A60-B459-E12E0C44BDECQ33707441-F01CECF2-CF5D-4B29-B8DE-99317942B600Q33773359-9A946317-A5B2-4A1D-8519-6D73CE388F94Q33805988-1E1B4D28-349D-482B-8FA3-9D4646716C9AQ33857031-306C503F-F74C-41BE-B846-B9D7F6886C2EQ33904277-F5F853D8-C1B1-4E53-A6B8-E1FC6704382EQ33944255-34A94BFE-9418-48FC-AA55-B25E5AB62B9DQ33962334-2AEA7A7C-E262-4A81-A306-E07DC7469B78Q34074921-66C2D0E3-4000-4ECD-BE35-5E33740643EBQ34088334-2EC9471A-7E72-4D42-ACEE-45A7B168B1B1Q34096874-E0BF8931-23AA-4C17-9BEF-F12C8FE1F340Q34106853-D3CF3460-204F-46C8-9CAF-22C5172B288DQ34162627-1F55BC90-F8D2-49FA-9B1E-92BFDE54D1BBQ34184665-F0862A97-E095-44A3-8A19-0F2B8CCBAB74Q34185759-DEF777A5-6796-490C-8C49-1B10B5CD26EBQ34314178-E092CC6D-C41C-45DA-B7DF-F46C301D03B9
P50
description
American pathologist
@en
Amerikaans pathologe
@nl
patolojiste american
@lfn
patóloga estadounidense
@es
patóloga estauxunidense
@ast
usona patologo
@eo
عالمة أمراض من الولايات المتحدة الأمريكية
@ar
name
Elaine Jaffe
@ast
Elaine Jaffe
@ca
Elaine Jaffe
@de
Elaine Jaffe
@en
Elaine Jaffe
@es
Elaine Jaffe
@fr
Elaine Jaffe
@nl
Elaine Jaffe
@sl
type
label
Elaine Jaffe
@ast
Elaine Jaffe
@ca
Elaine Jaffe
@de
Elaine Jaffe
@en
Elaine Jaffe
@es
Elaine Jaffe
@fr
Elaine Jaffe
@nl
Elaine Jaffe
@sl
altLabel
Elain S. Jaffe
@en
Elain Sarkin Jaffe
@en
prefLabel
Elaine Jaffe
@ast
Elaine Jaffe
@ca
Elaine Jaffe
@de
Elaine Jaffe
@en
Elaine Jaffe
@es
Elaine Jaffe
@fr
Elaine Jaffe
@nl
Elaine Jaffe
@sl
P1006
P214
P244
P268
P269
P1006
P1053
G-8981-2014
G-8984-2014
P106
P1343
P1960
g335aIwAAAAJ
P21
P213
0000 0000 8086 4677